What is it about?
When men are diagnosed with prostate cancer, groups of cancer cells are often found in more than one place in the prostate. The team wanted to know if this was due to changes in 'normal' prostate cells throughout the prostate. The team analysed DNA from 121 samples. These came from 37 men and included 'normal' tissue next to cancerous tissue, cancerous tissue and prostate tissue from men who did not have prostate cancer. The team showed that 'normal' prostate cells from men with prostate cancer had more mutations than 'normal' prostate cells from men without prostate cancer. Using the genetics of the samples analysed, the team can create maps to understand where the different mutations occurred. The team showed that in most men, the mutations in normal cells are different from the mutations in cancer cells. The team produced data suggesting that these mutations occur in a particular type of cell called stromal cells - cells that form a structure that supports other tissues. These findings suggest that the whole prostate is primed and ready to develop prostate cancer, driven by an as yet unknown biological process.
Photo by National Cancer Institute on Unsplash
Why is it important?
This work has improved our knowledge of how prostate cancer first starts to develop and might one day give us clues as to how to prevent it.
Read the Original
This page is a summary of: The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates, Molecular Cancer, September 2022, Springer Science + Business Media, DOI: 10.1186/s12943-022-01644-3.
You can read the full text:
The following have contributed to this page